Company news

NeoGenomics, Inc. news in 2024

NeoGenomics, Inc.'s news releases, calls and decks from 2024, newest first.

View company

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

December 10, 2024

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

December 8, 2024

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research

December 4, 2024

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

November 18, 2024

Felicia Williams Joins NeoGenomics Board of Directors

November 13, 2024

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

November 7, 2024

NeoGenomics Reports Third Quarter 2024 Results

November 4, 2024

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

October 21, 2024

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

October 14, 2024

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

October 7, 2024

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

September 22, 2024

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

September 10, 2024

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

August 28, 2024

NeoGenomics Reports Second Quarter 2024 Results

July 28, 2024

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

July 8, 2024

Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month

June 12, 2024

NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management

May 27, 2024

NeoGenomics Reports First Quarter 2024 Results

April 29, 2024

NeoGenomics Announces Senior Leadership Promotions

April 17, 2024

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024

April 8, 2024

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting

March 26, 2024

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report

March 19, 2024

NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference

February 29, 2024

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

February 19, 2024

NeoGenomics Signs Working with Cancer Pledge in Support of Employees

January 31, 2024

NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024

January 29, 2024

NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

January 1, 2024

Calls in 2024

Decks in 2024